🔴 Immunic is trading 12.07% down in pre-market with no company news or clear market-wide explanation

Immunic is trading at $14.50, down -12.07%, with no company news or clear market-wide explanation identified.

• No August 26–27, 2026 company news was listed by Immunic, including earnings, financing, regulatory, clinical-trial, analyst, or leadership announcements.
• The decline contrasts with pre-market strength: S&P 500 up 0.39% and Nasdaq up 0.93%.
• The latest listed release was August 11, 2026, covering second-quarter results and a corporate update.